Opleidingen details Stichting Amsterdam UMC Afdeling Amsterdam UMC Conferences & Events
12th Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment (ID nummer: 358930)
Nascholing met (fysieke) bijeenkomst(en)/ accreditatie per bijeenkomst
CategorieGeaccrediteerde puntenAccreditatieperiode
Cursus ZA613-11-2019 t/m 12-11-2020
Als u als professional deze cursus gevolgd heeft dan wordt de presentie ingegeven door de opleider.

Aim of NCHIV

The Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment, NCHIV, is a scientifically focused meeting. The aim of the conference is to review and share knowledge on the current status and new developments in understanding HIV pathogenesis, vaccine research and treatment. In addition, the conference aims to be a discussion platform for changes in the HIV epidemic in the Netherlands and to provide input for HIV public health and health care policy issues from a research perspective.

NCHIV provides an update and platform for discussion of new insights and developments in research on the pathogenesis, epidemiology, prevention and treatment of HIV. The one-day programme has three key elements: a core programme of sessions focussed on each of these four research themes; an extended lunch programme with poster presentations; and four invited plenary speakers.

 

 

BeroepsgroepBeroepsorganisatie
Accreditatiebureau Kwaliteitsregister V&V en Register ZorgprofessionalsVerpleegkundigen & Verzorgenden Nederland
Accreditatiebureau Sociale Geneeskunde (AbSg)KNMG-GAIA
Accreditatiebureau Verpleegkundig Specialisten RegisterVerpleegkundigen & Verzorgenden Nederland
Artsen Maatschappij + Gezondheid (KAMG)KNMG-GAIA
Hiv/AidsVerpleegkundigen & Verzorgenden Nederland
1 2 3 4 5 6
Senior and junior biomedical scientists in HIV/AIDS, HIV treating physicians, pharmacologists, infectious disease epidemiologists, (medical) microbiologists and HIV nurses are invited to attend NCHIV.
congres, lezingen, poster presentaties
185
300
The Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment, NCHIV, is a scientifically focused meeting. The aim of the conference is to review and share knowledge on the current status and new developments in understanding HIV pathogenesis, vaccine research and treatment. In addition, the conference aims to be a discussion platform for changes in the HIV epidemic in the Netherlands and to provide input for HIV public health and health care policy issues from a research perspective.
Nee
NCHIV provides an update and platform for discussion of new insights and developments in research on the pathogenesis, epidemiology, prevention and treatment of HIV. The one-day programme has three key elements: a core programme of sessions focussed on each of these four research themes; an extended lunch programme with poster presentations; and four invited plenary speakers.
Peter Reiss (SHM; AIGHD; AMC-UvA, Amsterdam)
Prof. Chloe Orkin (Barts Health NHS Trust, London, UK)
Ard van Sighem & Ferdinand Wit (Stichting HIV Monitoring; AIGHD; AMC-UvA)
Dr. Karoline Aebi-Popp (University Hospital Bern, Switzerland)
Prof. Waafa El Sadr (Columbia University, New York, USA
Dr. Anthony Fauci (NIH/NIAID, Bethesda, USA)
Peter Reiss (SHM; AIGHD; AMC-UvA)
Bestand  
NCHIV 2019 preliminary programme.pdf2-4-2019 10:20215 KB
Ja
13-11-2019
Tijd09:00 - 17:15
LocatieAmsterdam (NL) (Toon kaart)

De Congresorganisatie van Amsterdam UMC

Tafelbergweg 51
1105 BD
Amsterdam Zuidoost
Postbus 23213
1100 DS
Amsterdam
020-5668585